Shewring G S, Lazarus J H
Acta Endocrinol (Copenh). 1983 Jan;102(1):68-70. doi: 10.1530/acta.0.1020068.
The accumulation of 35S labelled methimazole (MMI) was examined in lymphocytes. No uptake of label was found in peripheral blood lymphocytes (PBL) from normal control subjects after in vitro incubation with the drug. Following administration of [35S]MMI to patients with Graves' hyperthyroidism PBL cell to plasma (C/P) 35S activity was greater than 1 in 4 of 11 patients and only in 1 of 7 other patients undergoing thyroidectomy. Thyroid lymphocytes from 2 of these patients showed some accumulation of activity. Following administration of [35S]MMI to normal rats C/P 35S ratios ranged from 1-5.6 but no 35S accumulation was found in PBL or thyroid lymphocytes from August strain rats in which experimental autoimmune thyroiditis had been produced. It is concluded that there is minimal, if any, significant accumulation of MMI in lymphocytes of patients with Graves' disease. The immunosuppressive action of MMI on lymphocyte antibody production must therefore by indirect.
研究了35S标记的甲巯咪唑(MMI)在淋巴细胞中的蓄积情况。在体外与该药物孵育后,未在正常对照受试者的外周血淋巴细胞(PBL)中发现放射性标记的摄取。给格雷夫斯甲状腺功能亢进症患者施用[35S]MMI后,11例患者中有4例的PBL细胞与血浆(C/P)的35S活性大于1,而在接受甲状腺切除术的其他7例患者中只有1例如此。其中2例患者的甲状腺淋巴细胞显示出一定的活性蓄积。给正常大鼠施用[35S]MMI后,C/P 35S比值在1至5.6之间,但在已诱发实验性自身免疫性甲状腺炎的奥古斯特品系大鼠的PBL或甲状腺淋巴细胞中未发现35S蓄积。得出的结论是,格雷夫斯病患者的淋巴细胞中即使有MMI的显著蓄积,也极为微量。因此,MMI对淋巴细胞抗体产生的免疫抑制作用必定是间接的。